An 8-month follow-up extension of the Vernal Keratoconjunctivitis Study, or VEKTIS, showed that continuous use of cyclosporine is safe and effective for the treatment of vernal keratoconjunctivitis in children and adolescents.
“The first and only paper on the use of cyclosporine dedicated to VKC treatment was published in 1986 by Prof. D. BenEzra, and then no clinical randomized studies were published. VKC is a rare eye disease in Europe, and it is commonly seasonal, so it is difficult to have the numbers to perform clinical studies. VEKTIS was a milestone (Read more...)
Uncategorized